Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Surgery	O

Sample	O
Name	O
:	O
Cardiac	B-test
Catheterization	I-test
-	O
5	O

Description	O
:	O
Left	B-test
heart	I-test
catheterization	I-test
with	O
coronary	B-test
angiography	I-test
,	O
vein	B-test
graft	I-test
angiography	I-test
and	O
left	B-test
ventricular	I-test
pressure	I-test
measurement	I-test
and	O
angiography	B-test
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

PROCEDURE	O
PERFORMED	O
:	O

1	O
.	O

Left	B-test
heart	I-test
catheterization	I-test
with	O
coronary	B-test
angiography	I-test
,	O
vein	B-test
graft	I-test
angiography	I-test
and	O
left	B-test
ventricular	I-test
pressure	I-test
measurement	I-test
and	O
angiography	B-test
.	O

2	O
.	O

Right	B-test
femoral	I-test
selective	I-test
angiogram	I-test
.	O

3	O
.	O

Closure	B-treatment
device	I-treatment
the	O
seal	O
the	O
femoral	O
arteriotomy	O
using	O
an	B-treatment
Angio	I-treatment
-	I-treatment
Seal	I-treatment
.	O

INDICATIONS	O
FOR	O
PROCEDURE	O
:	O
The	O
patient	O
with	O
known	B-problem
coronary	I-problem
atherosclerotic	I-problem
heart	B-bodyloc
disease	I-problem
and	O
multiple	O
risk	O
factors	O
of	O
coronary	B-bodyloc
disease	I-problem
,	O
who	O
had	O
her	B-test
last	I-test
coronary	I-test
arteriogram	I-test
performed	O
in	O
2004	B-temporal
.	O

She	O
has	O
had	O
complaints	O
of	O
progressive	B-problem
chest	B-bodyloc
discomfort	I-problem
,	O
and	O
has	O
ongoing	O
risks	O
including	O
current	O
smoking	O
,	O
diabetes	B-problem
,	O
hypertension	B-problem
,	O
hyperlipidemia	B-problem
to	O
name	O
a	O
few	O
.	O

The	O
decision	O
was	O
made	O
to	O
proceed	O
on	O
with	O
percutaneous	B-test
evaluation	I-test
and	O
possible	O
intervention	B-treatment
given	O
her	B-problem
known	I-problem
disease	I-problem
and	O
the	O
possibility	B-uncertain
of	O
disease	B-problem
progression	I-problem
.	O

DESCRIPTION	O
OF	O
PROCEDURE	O
:	O
After	O
informed	O
consent	O
was	O
obtained	O
,	O
The	O
patient	O
was	O
taken	O
to	O
cardiac	O
catheterization	O
lab	O
where	O
her	B-treatment
procedure	I-treatment
was	O
performed	O
.	O

She	O
was	O
prepped	O
and	O
prepared	O
on	O
the	O
table	O
;	O
after	O
which	O
,	O
her	O
right	O
groin	O
was	O
locally	O
anesthetized	O
with	O
1	B-strength
%	I-strength
lidocaine	B-drug
.	O

Then	O
,	O
a	B-treatment
6	I-treatment
-	I-treatment
French	I-treatment
sheath	I-treatment
was	O
inserted	O
into	O
the	O
right	O
femoral	O
artery	O
over	O
a	O
standard	O
0	O
.	O
035	O
guide	O
wire	O
.	O

Coronary	B-test
angiography	I-test
and	O
left	B-test
ventricular	I-test
measurement	I-test
and	O
angiography	B-test
were	O
performed	O
using	O
a	O
6	O
-	O
French	O
JL4	O
diagnostic	O
catheter	O
to	O
image	O
the	O
left	O
coronary	O
artery	O
.	O

A	O
6	O
-	O
French	O
JR4	O
diagnostic	O
catheter	O
to	O
image	O
the	O
right	O
groin	O
and	O
her	O
artery	O
and	O
the	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
conduit	I-treatment
.	O

Subsequently	O
,	O
a	B-treatment
6	I-treatment
-	I-treatment
French	I-treatment
angled	I-treatment
pigtail	I-treatment
catheter	I-treatment
was	O
used	O
to	O
measure	O
left	B-test
ventricular	I-test
pressures	I-test
and	O
to	O
perform	O
a	B-treatment
power	I-treatment
injection	I-treatment
,	O
a	B-test
left	I-test
ventriculogram	I-test
at	O
8	B-labvalue
mL	I-labvalue
per	O
second	O
for	O
a	O
total	O
of	O
30	O
mL	O
.	O

At	O
the	O
conclusion	O
of	O
the	B-test
diagnostic	I-test
evaluation	I-test
,	O
the	O
patient	O
had	O
selective	B-test
arteriography	I-test
of	I-test
her	I-test
right	I-test
femoral	I-test
artery	I-test
,	O
which	O
showed	O
the	O
right	B-bodyloc
femoral	I-bodyloc
artery	I-bodyloc
to	O
be	O
free	O
of	O
significant	B-problem
atherosclerotic	I-problem
plaque	I-problem
.	O

Did	O
have	O
a	O
normal	O
bifurcation	O
into	O
the	O
superficial	O
femoral	O
and	O
profunda	O
femoris	O
arteries	O
and	O
to	O
have	O
an	B-test
arteriotomy	I-test
that	O
was	O
in	O
the	O
common	O
femoral	O
artery	O
away	O
from	O
the	O
bifurcation	O
.	O

As	O
such	O
,	O
an	O
initial	O
attempt	O
to	O
advance	O
a	B-treatment
Perclose	I-treatment
device	I-treatment
failed	O
to	O
allow	O
the	B-treatment
device	I-treatment
descend	O
to	O
_	O
_	O
_	O
_	O
_	O
tract	O
and	O
into	O
the	O
appropriate	O
position	O
within	O
the	O
artery	O
.	O

As	O
such	O
,	O
the	B-treatment
Perclose	I-treatment
was	O
never	O
deployed	O
and	O
was	O
removed	O
intact	O
over	O
the	O
wire	O
from	O
the	O
system	O
.	O

We	O
then	O
replaced	O
this	O
with	O
a	B-treatment
6	I-treatment
-	I-treatment
French	I-treatment
Angio	I-treatment
-	I-treatment
Seal	I-treatment
which	O
was	O
used	O
to	O
seal	O
the	O
femoral	O
arteriotomy	O
with	O
achievement	O
of	O
hemostasis	B-treatment
.	O

The	O
patient	O
was	O
subsequently	O
dispositioned	O
back	O
to	O
the	O
MAC	O
Unit	O
where	O
she	O
will	O
complete	O
her	B-treatment
bedrest	I-treatment
prior	O
to	O
her	O
disposition	O
to	O
home	O
.	O

HEMODYNAMIC	O
DATA	O
:	O
Opening	B-problem
aortic	B-bodyloc
pressure	I-problem
125	O
/	O
60	O
,	O
left	B-test
ventricular	I-test
pressure	I-test
108	B-labvalue
/	I-labvalue
4	I-labvalue
with	O
an	B-test
end	I-test
-	I-test
diastolic	I-test
pressure	I-test
of	O
16	B-labvalue
.	O

There	O
was	O
no	B-negation
significant	B-problem
gradient	I-problem
across	I-problem
the	I-problem
aortic	B-bodyloc
valve	I-bodyloc
on	O
pullback	O
from	O
the	O
left	O
ventricle	O
.	O

Left	B-test
ventricular	I-test
ejection	I-test
fraction	I-test
was	O
55	B-labvalue
%	I-labvalue
.	O

Mitral	B-bodyloc
regurgitation	I-problem
was	O
less	O
than	O
or	O
equal	O
to	O
1	O
+	O
.	O

There	O
was	O
normal	O
wall	O
motion	O
in	O
the	O
RAO	O
projection	O
.	O

CORONARY	B-test
ANGIOGRAM	I-test
:	O
The	O
left	O
main	O
coronary	O
artery	O
had	O
mild	B-severity
atherosclerotic	I-problem
plaque	I-problem
.	O

The	O
proximal	O
LAD	B-bodyloc
was	O
100	O
%	O
occluded	B-problem
.	O

The	O
left	B-bodyloc
circumflex	I-bodyloc
had	O
mild	B-severity
diffuse	I-problem
atherosclerotic	I-problem
plaque	I-problem
.	O

The	O
obtuse	O
marginal	O
branch	O
which	O
operates	O
as	O
an	O
OM	O
-	O
2	O
had	O
a	B-problem
mid	I-problem
approximately	I-problem
80	I-problem
%	I-problem
stenosis	I-problem
at	O
a	O
kink	O
in	O
the	O
artery	O
.	O

This	O
appears	O
to	O
be	O
the	O
area	O
of	O
a	B-treatment
prior	I-treatment
anastomosis	I-treatment
,	O
the	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
OM	I-treatment
.	O

This	O
is	O
a	O
very	O
small	O
-	O
caliber	O
vessel	O
and	O
is	O
1	O
.	O
5	O
-	O
mm	O
in	O
diameter	O
at	O
best	O
.	O

The	O
right	O
coronary	O
artery	O
is	O
dominant	O
.	O

The	O
native	O
right	O
coronary	O
artery	O
had	O
mild	B-severity
proximal	I-problem
and	I-problem
mid	I-problem
atherosclerotic	I-problem
plaque	I-problem
.	O

The	O
distal	O
right	O
coronary	O
artery	O
has	O
an	B-problem
approximate	I-problem
40	I-problem
%	I-problem
stenosis	I-problem
.	O

The	O
posterior	B-bodyloc
left	I-bodyloc
ventricular	I-bodyloc
branch	I-bodyloc
has	O
a	O
proximal	O
50	O
to	O
60	O
%	O
stenosis	B-problem
.	O

The	O
proximal	O
PDA	O
has	O
a	O
40	O
to	O
50	O
%	O
stenosis	B-problem
.	O

The	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
right	I-treatment
PDA	I-treatment
is	O
widely	O
patent	O
.	O

There	O
was	O
competitive	O
flow	O
noted	O
between	O
the	O
native	O
right	O
coronary	O
artery	O
and	O
the	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
PDA	I-treatment
.	O

The	O
runoff	O
from	O
the	O
PDA	O
is	O
nice	O
with	O
the	O
native	O
proximal	O
PDA	O
and	O
PLV	B-problem
disease	I-problem
as	O
noted	O
above	O
.	O

There	O
is	O
also	O
some	B-problem
retrograde	I-problem
filling	I-problem
of	I-problem
the	I-problem
right	B-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
from	O
the	O
runoff	O
of	O
this	B-treatment
graft	I-treatment
.	O

The	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
is	O
widely	O
patent	O
.	O

The	O
LAD	O
beyond	O
the	O
distal	O
anastomosis	O
is	O
a	O
relatively	O
small	O
-	O
caliber	O
vessel	O
.	O

There	O
is	O
some	B-problem
retrograde	I-problem
filling	I-problem
that	O
allows	O
some	O
filling	O
into	O
a	O
more	O
proximal	O
diagonal	O
branch	O
.	O

The	B-treatment
saphenous	B-bodyloc
vein	I-bodyloc
graft	I-bodyloc
to	I-treatment
the	I-treatment
obtuse	I-treatment
marginal	I-treatment
was	O
known	O
to	O
be	O
occluded	B-problem
from	O
the	B-test
prior	I-test
study	I-test
in	O
2004	B-temporal
.	O

Overall	O
,	O
this	B-test
study	I-test
does	O
not	O
look	O
markedly	O
different	O
than	O
the	B-treatment
procedure	I-treatment
performed	O
in	O
2004	B-temporal
.	O

CONCLUSION	O
:	O
100	O
%	O
proximal	O
LAD	B-bodyloc
mild	B-severity
left	B-bodyloc
circumflex	I-bodyloc
disease	I-problem
with	O
an	O
OM	O
that	O
is	O
a	O
small	O
-	O
caliber	O
vessel	O
with	O
an	B-problem
80	I-problem
%	I-problem
lesion	I-problem
at	O
a	O
kink	O
that	O
is	O
no	O
amenable	O
to	O
percutaneous	B-treatment
intervention	I-treatment
.	O

The	O
native	O
right	B-bodyloc
coronary	I-bodyloc
artery	I-bodyloc
has	O
mild	B-severity
to	I-problem
moderate	B-severity
distal	I-problem
disease	I-problem
with	O
moderate	B-severity
PLV	I-problem
and	O
PDA	B-bodyloc
disease	I-problem
.	O

The	B-treatment
saphenous	B-bodyloc
vein	I-bodyloc
graft	I-bodyloc
to	I-treatment
the	I-treatment
OM	I-treatment
is	O
known	O
to	O
be	O
100	O
%	O
occluded	B-problem
.	O

The	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
PDA	I-treatment
and	O
the	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
LAD	I-treatment
are	O
open	O
.	O

Normal	O
left	O
ventricular	O
systolic	O
function	O
.	O

PLAN	O
:	O
The	O
plan	O
will	O
be	O
for	O
continued	B-treatment
medical	I-treatment
therapy	I-treatment
and	O
risk	B-treatment
factor	I-treatment
modification	I-treatment
.	O

Aggressive	B-treatment
antihyperlipidemic	I-treatment
and	O
antihypertensive	B-drug
control	I-treatment
.	O

The	O
patient	O
'	O
s	O
goal	O
LDL	B-test
will	O
be	O
at	O
or	O
below	O
70	O
with	O
triglyceride	B-test
level	I-test
at	O
or	O
below	O
150	B-labvalue
,	O
and	O
it	O
is	O
very	O
imperative	O
that	O
the	O
patient	O
stop	O
smoking	O
.	O

After	O
her	B-treatment
bedrest	I-treatment
is	O
complete	O
,	O
she	O
will	O
be	O
dispositioned	O
to	O
home	O
,	O
after	O
which	O
,	O
she	O
will	O
be	O
following	O
up	O
with	O
me	O
in	O
the	O
office	O
within	O
1	O
month	O
.	O

We	O
will	O
also	O
plan	O
to	O
perform	O
a	B-test
carotid	I-test
duplex	I-test
Doppler	I-test
ultrasound	I-test
to	O
evaluate	B-uncertain
her	B-problem
carotid	B-bodyloc
bruits	I-problem
.	O

Keywords	O
:	O

surgery	B-treatment
,	O
catheterization	B-test
,	O
vein	B-treatment
graft	I-treatment
,	O
angiography	B-test
,	O
angiogram	B-test
,	O
angio	B-treatment
-	I-treatment
seal	I-treatment
,	O
closure	B-treatment
device	I-treatment
,	O
coronary	B-problem
atherosclerotic	I-problem
heart	B-bodyloc
disease	I-problem
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
,	O
ventricular	B-test
pressure	I-test
,	O
coronary	O
artery	O
,	O
saphenous	O
vein	O
,	O
atherosclerotic	B-problem
,	O
coronary	O
,	O
artery	O
,	O
bifurcation	O
,	O
pda	O
,	O
ventricular	O
,	O
saphenous	O
,	O

